PBI · Pitney Bowes
Conviction · Low · more likely to lag the S&P 500 over the next three months
Wrong if: a daily close above $17.44
Note written ·
Price against the kill line
10.6% clear of its kill line on the 13 November 2026 close.
How to read this
This note expects the shares to lag the market, so its kill line sits above the price: a close above the red mark would prove the view wrong. Prices run from low on the left to high on the right. The dot is where the stock closed on 13 November 2026, left of the mark while it is below the line; a dot right of the mark has closed through it.
The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.
The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides
Three months against the kill line
Daily closes, to . Red: the kill line, a daily close above $17.44, on record since 10 November 2026. The shares are down 2.7% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.
Kill line
A daily close above $17.44, the close before the results of 29 October 2026 (28 October 2026), would show the shares leading the S&P 500 and prove this call wrong.
Research onlyNot in the portfolio.
Key figures from the filings · Technology
Quarter to 30 September 2026, filed 29 October 2026; valuation at the 13 November 2026 close
- Revenue, latest quarter ($M)
- 456
- Revenue, change on a year (%)
- −0.8
- Operating margin (%)
- 15.4
- Free cash flow, four quarters ($M)
- 505
- Net cash, cash less debt ($M)
- −1,606
- Price to earnings (×)
- 11.2
- Enterprise value to sales (×)
- 2.0
- Enterprise value to operating income (×)
- 14.6
All filed numbers
What Pitney Bowes reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .
| Quarter to | Revenue ($M) | On a year (%) | Operating margin (%) |
|---|---|---|---|
| first filed | 456 | −0.8 | 15.4 |
| first filed | 452 | −2.3 | 14.5 |
| first filed | 477 | −3.2 | 16.9 |
| first filed | 478 | −7.5 | 8.0 |
| first filed | 460 | −8.0 | 14.8 |
| first filed | 462 | −5.7 | 8.5 |
| Pre-tax income ($M) | 70.1 |
| Net income ($M) four quarters: 188 | 52.7 |
| Diluted shares, change on a year (%) against the quarter to 30 September 2025 | −17.4 |
| Operating cash flow ($M) | 570 |
| Capital spending ($M) | 65.3 |
| Free cash flow ($M) | 505 |
| Cash and short-term investments ($M) | 281 |
| Debt ($M) long-term debt | 1,887 |
| Net cash, cash less debt ($M) | −1,606 |
| Deferred revenue ($M) −8.0% on a year | 66.9 |
| Backlog, orders not yet delivered ($M) | Not reported |
| Receivables ($M) | 162 |
| Inventory ($M) | 63.0 |
| Shareholders' equity ($M) | −837 |
| Market value ($M) | 2,113 |
| Enterprise value, market value plus net debt ($M) | 3,720 |
| Enterprise value to sales (×) | 2.0 |
| Enterprise value to operating income (×) | 14.6 |
| Price to earnings (×) | 11.2 |
| Price to book value (×) | Not meaningful |
| Free-cash-flow yield (%) | 23.9 |
Short interest (FINRA, settled 15 October 2026, published 26 October 2026): 13.1% of shares outstanding sold short, 11.1 days of average trading to cover, −4.7% since the previous report.
| Window | Bought | Sold |
|---|---|---|
| 90 daysfrom | $0 | $9.8M |
| 12 monthsfrom | $104K | $92.4M |
The thesis
Pitney Bowes is still raising earnings through cost cuts, debt reduction and a smaller share count while revenue barely moves, but the shares have fallen despite a better-than-expected third quarter, so the market is not rewarding the story. The 28 October 2026 report beat estimates and narrowed fiscal 2026 adjusted earnings per share (EPS) guidance to $1.58–$1.67 from $1.55–$1.70; the next settling event is the fourth-quarter report, expected around late February 2027.
The shares closed at $15.40 on 9 November 2026, 16.3% below the $18.40 52-week high, with the 14-day relative strength index (RSI) at 23.2 and a three-month price change of −7.2% (adjusted daily closes). The prior close of $17.29 on 27 October 2026 means the decline came after the print. StockStory reported the stock trading at $17.50 on 29 October 2026, so the drop followed the first day of trading. The story is well known and losing support: the guidance raises and debt actions are well known, and the shares have fallen about $1.90 since 27 October 2026 with no company announcement in news through 30 October 2026 that explains it.
The decline took the shares below $16.40. The case now rests on cash generation, with the full-year adjusted free cash flow range raised to $380–$420 million, against a share price that is trending down.
Bullish and bearish views on Pitney Bowes Inc.
The bull case on Pitney Bowes Inc. (PBI), in brief: third-quarter earnings beat. The bear case: buybacks slowed sharply.
Bull case
- Third-quarter earnings beat. Adjusted EPS was $0.42, up 35% from $0.31 a year earlier, against a $0.35 estimate cited by Benzinga. Revenue of $456 million, down 1% from $460 million, beat the $452.7 million estimate (Q3 2026 earnings release, 28 October 2026).
- Cash flow guidance went up. Fiscal 2026 adjusted free cash flow guidance rose to $380–$420 million from $360–$410 million. Third-quarter adjusted free cash flow was $147 million versus $60 million a year earlier (earnings release, 28 October 2026).
- Revenue guidance floor was lifted. The company raised the low end of fiscal 2026 revenue guidance to $1.83 billion, keeping the top at $1.86 billion. It described this as establishing a higher midpoint.
- Presort returned to growth. Presort revenue was $151 million, up 1%, and volume was 3.4 billion pieces, up 4%. Adjusted segment EBIT (earnings before interest and taxes) was $32 million, down 2%, a recovery from $20 million in the second quarter. StockStory reported management saying the exit of competitor PCI let it absorb about 15% more Presort volume.
- Debt is shrinking. The company retired $148 million of debt in the third quarter, including $46 million through the tender offer for the 2037 and 2043 notes, and held $268.5 million of cash on 30 September 2026. The Term Loan B margin cut and S&P's upgrade to BB- from B+ were announced 30 September 2026.
- Bank reporting change is planned. The CEO said the company remains on track to report Pitney Bowes Bank as an independent segment in 2027 (Benzinga headline, 28 October 2026).
Bear case
- Buybacks slowed sharply. The company repurchased about 1.0 million shares for $17 million in the third quarter at an average $16.84, against $53 million in the second quarter. Weighted-average diluted shares were 140.7 million, versus 139 million in the second quarter and 170.4 million a year earlier.
- Guidance midpoint did not move. The new $1.58–$1.67 adjusted EPS range has the same midpoint as the prior $1.55–$1.70 range. Benzinga cited a $1.68 consensus estimate, above the top of the new range.
- Adjusted EBIT guidance was narrowed, not raised. The range moved to $450–$470 million from $445–$475 million (earnings release, 28 October 2026).
- A 2027 revenue headwind is named. StockAnalysis-style summaries aside, StockStory reported management citing a revenue and margin headwind in 2027 from the loss of a legacy fulfillment contract, and said new Presort volumes arrived late in the quarter at lower pricing.
- The strategic review is silent. The 28 October 2026 earnings release does not discuss the Strategic Review Committee announced 30 June 2026. It shows $4.8 million of third-quarter transaction and strategic review costs, $13.0 million year to date.
- Insider disposals into strength. Form 4 filings showed ten disposals attributed to CEO Kurt Wolf between 8 May 2026 and 3 August 2026, including 430,443 shares at an average $18.23 on 30 July 2026. No later filings are in the record reviewed.
Price setup
The shares closed at $15.40 on 9 November 2026. The 52-week high is $18.40, 16.3% above that close. The RSI of 23.2 is deeply oversold by the usual reading below 30. The shares have lost the $16.40 level, which sat under the 21 August 2026 close of $16.48.
The decline of the close from $17.29 on 27 October 2026 to $15.40 on 9 November 2026 happened after an earnings beat. That gap between results and price is the main fact for the near term: either the market is discounting the slower buybacks and 2027 headwinds, or the move is a sell-off that has run ahead of the numbers. The next reports of share repurchases and the fourth-quarter guidance for 2027 decide which.
Catalysts ahead
- 16 November 2026: Record date for the $0.10 quarterly dividend, payable 8 December 2026. Confirms the company is maintaining its cash return alongside buybacks and debt paydown.
- ~25 February 2027 (est.): Fourth-quarter and full-year 2026 results. Settles whether adjusted EPS lands inside $1.58–$1.67 and gives the first 2027 outlook after the legacy contract loss.
What would change the view
A daily close above $17.44, the close before the results of 29 October 2026 (28 October 2026), would show the shares leading the S&P 500 and prove this call wrong.
What it trades with
Pitney Bowes trades on its own capital-return and debt story more than on a sector. Its Presort segment depends on mail volume, fuel and driver costs, and its Bank segment on credit and funding costs, so it can move with small-cap industrials and rates. Coverage is thin, so a single target change can shift the consensus. No theme currently drives the shares.
The evidence, claim by claim (7)
- Q3 2026 revenue $456M, down 1% from $460M; adjusted EPS $0.42 vs $0.31; adjusted EBIT $114M, up 6%; adjusted free cash flow $147M vs $60M. Q3 2026 earnings release (Form 8-K exhibit 99.1) · as of
- FY2026 guidance: adjusted EPS $1.58–$1.67 (was $1.55–$1.70); revenue $1.83–$1.86B (was $1.80–$1.86B); adjusted EBIT $450–$470M; adjusted free cash flow $380–$420M (was $360–$410M). Q3 2026 earnings release (Form 8-K exhibit 99.1) · as of
- Presort Q3 revenue $151M, up 1%; adjusted segment EBIT $32M, down 2%; volume 3.4B pieces, up 4%. Q3 2026 earnings release (Form 8-K exhibit 99.1) · as of
- Q3 repurchases about 1.0M shares for $17M at an average $16.84; another 0.6M shares for $11M from Oct. 1 to Oct. 23; diluted shares 140.7M vs 170.4M a year earlier. Q3 2026 earnings release (Form 8-K exhibit 99.1) · as of
- Debt retired in Q3 was $148M, including $46M via tender offer; cash and equivalents were $268.5M at Sept. 30. Q3 2026 earnings release (Form 8-K exhibit 99.1) · as of
- Quarterly dividend of $0.10 per share, record date 16 November 2026, payable 8 December 2026. Q3 2026 earnings release (Form 8-K exhibit 99.1) · as of
- Close of $15.40, 16.3% below the $18.40 52-week high; RSI(14) 23.2; three-month price change −7.2%. Split/dividend-adjusted daily bars · as of
Sources
- PITNEY BOWES INC /DE/ - Form 8-K - FY2026 · sec.gov
- PITNEY BOWES INC /DE/ - Form 10-Q - FY2026 · sec.gov
- StockStory ·
Related · shared themes
U
Unity Software
Unity Software's advertising turnaround and reported takeover interest make the shares modestly more likely than not to beat the S&P 500…
BETR
Better Home & Finance Holding
Better Home & Finance shares are more likely to lag the S&P 500 over three months: volume fell from $496 million in July to $345 million in…
JNJ
Johnson & Johnson
Johnson & Johnson's drug approvals keep coming, but weak medical devices and $1.36 per share of 2027 deal dilution leave the shares more…
PD
PagerDuty
PagerDuty's shares are more likely to lag the S&P 500 over three months because a 32.1% three-month rally has run ahead of revenue growth…